• Exchange: Indonesia
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Taisho Pharmaceutical Indonesia Tbk PT

+ Add to Watchlist

SQBI:IJ

313,500 IDR 7,500 2.45%

As of 23:41:49 ET on 09/18/2014.

Snapshot for Taisho Pharmaceutical Indonesia Tbk PT (SQBI)

Open: 330,000 Day's Range: 313,500 - 330,000 Volume: 300
Previous Close: 306,000 52wk Range: 269,000 - 330,000 1-Yr Rtn: +21.59%

Stock Chart for SQBI

No chart data available.
  • SQBI:IJ 313,500
  • 1D
  • 1M
  • 1Y
306,000
Interactive SQBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SQBI

Current P/E Ratio (ttm) 17.7744
Estimated P/E(-) -
Relative P/E vs. JCI 0.8535
Earnings Per Share (ttm) 17,637.7743
Est. EPS -
Est. PEG Ratio -
Market Cap (M IDR) 304,722.00
Shares Outstanding (M) 0.97
30 Day Average Volume 63
Price/Book (mrq) 10.6092
Price/Sale (ttm) 6.2949
Dividend Indicated Gross Yield 4.47%
Cash Dividend (IDR) 14,000.0000
Dividend Ex-Date 06/13/2014
5 Year Dividend Growth 11.84%
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SQBI

  • Revenue
  • Net Income (M/IDR)
  • Profit Margin (%)

Company Profile & Key Executives for SQBI

PT Taisho Pharmaceutical Indonesia Tbk manufactures pharmaceutical products and health care products. The Company's products are marketed under a variety of branded names.

Yasuhiro KurataPresident CommissionerJun KurodaPresident Director
Masashi NakauraDirectorAdeel Akhlaq HassanDirector
More Company Profile & Key Executives for SQBI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil